A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901)

BACKGROUND: To evaluate the efficacy and safety of toripalimab combined with neoadjuvant chemoradiotherapy (NCRT) for locally advanced esophageal squamous cell carcinoma (ESCC). METHODS: In this single arm, phase II trial, 44 ESCC patients were enrolled from December 2019 to July 2021 at Sun Yat-sen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rui, Liu, Qianwen, Li, Qiaoqiao, Zhu, Yujia, Zhao, Lei, Liu, Shiliang, Chen, Baoqing, Liu, Mengzhong, Hu, Yonghong, Lin, Ting, Li, Jibin, Chen, Jiyang, Lv, Yingxin, Fu, Jianhua, Xi, Mian, Yang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407031/
https://www.ncbi.nlm.nih.gov/pubmed/37560259
http://dx.doi.org/10.1016/j.eclinm.2023.102118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407031/
https://www.ncbi.nlm.nih.gov/pubmed/37560259
http://dx.doi.org/10.1016/j.eclinm.2023.102118

Ejemplares similares